JP2025503644A5 - - Google Patents
Info
- Publication number
- JP2025503644A5 JP2025503644A5 JP2024541171A JP2024541171A JP2025503644A5 JP 2025503644 A5 JP2025503644 A5 JP 2025503644A5 JP 2024541171 A JP2024541171 A JP 2024541171A JP 2024541171 A JP2024541171 A JP 2024541171A JP 2025503644 A5 JP2025503644 A5 JP 2025503644A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- cdr
- antibody
- antigen
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263298423P | 2022-01-11 | 2022-01-11 | |
| US63/298,423 | 2022-01-11 | ||
| PCT/US2023/060431 WO2023137291A1 (en) | 2022-01-11 | 2023-01-10 | Anti-cd94 antibody and chimeric antigen receptor and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025503644A JP2025503644A (ja) | 2025-02-04 |
| JP2025503644A5 true JP2025503644A5 (https=) | 2026-01-19 |
Family
ID=87279811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024541171A Pending JP2025503644A (ja) | 2022-01-11 | 2023-01-10 | 抗ｃｄ９４抗体及びキメラ抗原受容体ならびにそれらの使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250101113A1 (https=) |
| EP (1) | EP4463183A4 (https=) |
| JP (1) | JP2025503644A (https=) |
| KR (1) | KR20240134948A (https=) |
| CN (1) | CN119095615A (https=) |
| AU (1) | AU2023208020A1 (https=) |
| CA (1) | CA3246685A1 (https=) |
| MX (1) | MX2024008633A (https=) |
| WO (1) | WO2023137291A1 (https=) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004272607B2 (en) * | 2003-09-11 | 2008-11-06 | Cornerstone Therapeutics Inc. | Monoclonal antibodies against HMGB1 |
| RU2017105425A (ru) * | 2014-08-28 | 2018-09-28 | Академиш Зикенхёйс Лейден Х.О.Д.Н. Люмк | Комбинации антитела против cd94/nkg2a и/или cd94/nkg2b и вакцины |
| EP3558367A1 (en) * | 2016-12-23 | 2019-10-30 | Monash University | Antibodies to il-37 |
| CA3055256A1 (en) * | 2017-03-09 | 2018-09-13 | Mab Discovery Gmbh | Antibodies specifically binding to human il-1r7 |
| AU2019346335B2 (en) * | 2018-09-28 | 2024-07-25 | Massachusetts Institute Of Technology | Collagen-localized immunomodulatory molecules and methods thereof |
-
2023
- 2023-01-10 CN CN202380021673.2A patent/CN119095615A/zh active Pending
- 2023-01-10 AU AU2023208020A patent/AU2023208020A1/en active Pending
- 2023-01-10 EP EP23740768.9A patent/EP4463183A4/en active Pending
- 2023-01-10 JP JP2024541171A patent/JP2025503644A/ja active Pending
- 2023-01-10 MX MX2024008633A patent/MX2024008633A/es unknown
- 2023-01-10 US US18/728,332 patent/US20250101113A1/en active Pending
- 2023-01-10 WO PCT/US2023/060431 patent/WO2023137291A1/en not_active Ceased
- 2023-01-10 CA CA3246685A patent/CA3246685A1/en active Pending
- 2023-01-10 KR KR1020247026533A patent/KR20240134948A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7575100B2 (ja) | 免疫細胞活性化のための二重特異性抗体 | |
| JP7611931B2 (ja) | ガイダンス及びナビゲーションコントロール（ｇｎｃ）抗体様タンパク質、その製造方法及び使用方法 | |
| CN117024592B (zh) | 抗b7h3抗体及其用途 | |
| US20250000976A1 (en) | Anti-bcma single domain antibodies and therapeutic constructs | |
| WO2022222530A1 (zh) | 抗tigit抗体及其用途 | |
| JP2024507693A5 (https=) | ||
| WO2022224997A1 (ja) | 抗ｃｌｄｎ４－抗ｃｄ１３７二重特異性抗体 | |
| Lin et al. | Recent progress in antitumor functions of the intracellular antibodies | |
| US20250101104A1 (en) | Bispecific molecule with tunable affinity to a targeted antigen | |
| CN113004416B (zh) | 靶向her2-cd137双特异性抗体的构建及其应用 | |
| KR20230104229A (ko) | Cd3에 결합하는 폴리펩티드 구축물 | |
| JP2025503644A5 (https=) | ||
| CN119894930A (zh) | 一种双特异性抗体及其应用 | |
| US20250304706A1 (en) | Anti-taa/anti-cd3 multispecific antibody | |
| WO2024027828A1 (en) | Multi-specific antibodies targeting a dimerizable tumor antigen and an immunostimulatory antigen | |
| WO2024027120A1 (en) | Multi-specific polypeptide complexes | |
| TWI918721B (zh) | Egfr結合複合物及其製備和使用方法 | |
| WO2024149381A1 (en) | Multi-specific polypeptide complexes | |
| WO2025218621A1 (zh) | 靶向muc1的抗原结合蛋白 | |
| JP2025087939A (ja) | がん治療におけるｐｄ－１シグナル阻害剤との組み合わせによる抗ｔｓｐａｎ８－抗ｃｄ３二重特異性抗体の使用 | |
| CN119768434A (zh) | 一种双特异性抗体及其应用 | |
| WO2024193668A1 (zh) | 抗ctla-4/抗tigit双特异性抗体及其应用 | |
| CN117586408A (zh) | 一种结合tnfr2和b7h3的双特异性抗体 | |
| CN117586411A (zh) | 一种结合tnfr2和ccr8的双特异性抗体 | |
| WO2024210072A1 (ja) | キメラタンパク質、核酸、ベクター、ｔ細胞又はｎｋ細胞、医薬組成物、組み合わせ物、組み合わせ医薬、及び標的抗原結合タンパク質 |